Live feed
Filing
SCHEDULE 13G
SCHEDULE 13G0001172661-25-001363·Deep Track Capital, LP
Schedule 13G ownership disclosure
Immunovant Inc
Common Stock, $0.0001 par value per share · CUSIP: 45258J102
Event date: 2025-03-19
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Deep Track Capital, LP
Shares: 9,500,000.00 · Class: 5.59%
- Deep Track Biotechnology Master Fund, Ltd.
Shares: 9,500,000.00 · Class: 5.59%
- David Kroin
Shares: 9,500,000.00 · Class: 5.59%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001172661-25-001363
- Form type
- SCHEDULE 13G
- Filer
- Deep Track Capital, LP
- CIK
- CIK 1856083
- Filed
- Mar 26, 2025
- Reporting period
- Mar 19, 2025
- Description
- Schedule 13G beneficial ownership